tretinoin and Genetic-Diseases--Inborn

tretinoin has been researched along with Genetic-Diseases--Inborn* in 4 studies

Reviews

3 review(s) available for tretinoin and Genetic-Diseases--Inborn

ArticleYear
[Human pluripotent stem cells: opening key for pathological modeling].
    Medecine sciences : M/S, 2011, Volume: 27, Issue:4

    Topics: Adult; Cell Differentiation; Cell Line; Coculture Techniques; Genetic Diseases, Inborn; Hedgehog Proteins; Humans; Membrane Proteins; Models, Biological; Motor Neurons; Myotonic Dystrophy; Myotonin-Protein Kinase; Nerve Tissue Proteins; Neurites; Pluripotent Stem Cells; Protein Serine-Threonine Kinases; Research Design; Research Embryo Creation; Stromal Cells; Synapses; Tretinoin; Trinucleotide Repeat Expansion

2011
Dynamic and reversibility of heterochromatic gene silencing in human disease.
    Cell research, 2005, Volume: 15, Issue:9

    In eukaryotic organisms cellular fate and tissue specific gene expression are regulated by the activity of proteins known as transcription factors that by interacting with specific DNA sequences direct the activation or repression of target genes. The post genomic era has shown that transcription factors are not the unique key regulators of gene expression. Epigenetic mechanisms such as DNA methylation, post-translational modifications of histone proteins, remodeling of nucleosomes and expression of small regulatory RNAs also contribute to regulation of gene expression, determination of cell and tissue specificity and assurance of inheritance of gene expression levels. The relevant contribution of epigenetic mechanisms to a proper cellular function is highlighted by the effects of their deregulation that cooperate with genetic alterations to the development of various diseases and to the establishment and progression of tumors.

    Topics: Chromatin; DNA; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; Gene Silencing; Genetic Diseases, Inborn; Heterochromatin; Histones; Humans; Leukemia, Myeloid, Acute; Models, Biological; Neoplasms; Nucleosomes; Oligodeoxyribonucleotides; Protein Processing, Post-Translational; Protein Structure, Tertiary; RNA; RNA Interference; Sequence Analysis, DNA; Transcription, Genetic; Tretinoin

2005
Genes, pollutants and human diseases.
    Quarterly reviews of biophysics, 1978, Volume: 11, Issue:4

    Topics: Biological Evolution; Carcinogens; Chronic Disease; DNA Repair; Environmental Pollutants; Genetic Diseases, Inborn; Humans; Mutation; Neoplasms; Tretinoin; Xeroderma Pigmentosum

1978

Other Studies

1 other study(ies) available for tretinoin and Genetic-Diseases--Inborn

ArticleYear
Overproduction of bioactive retinoic acid in cells expressing disease-associated mutants of retinol dehydrogenase 12.
    The Journal of biological chemistry, 2007, Dec-07, Volume: 282, Issue:49

    Retinol dehydrogenase 12 (RDH12) is an NADP(+)-dependent oxidoreductase that in vitro catalyzes the reduction of all-trans-retinaldehyde to all-trans-retinol or the oxidation of retinol to retinaldehyde depending on substrate and cofactor availability. Recent studies have linked the mutations in RDH12 to severe early-onset autosomal recessive retinal dystrophy. The biochemical basis of photoreceptor cell death caused by mutations in RDH12 is not clear because the physiological role of RDH12 is not yet fully understood. Here we demonstrate that, although bi-directional in vitro, in living cells, RDH12 acts exclusively as a retinaldehyde reductase, shifting the retinoid homeostasis toward the increased levels of retinol and decreased levels of bioactive retinoic acid. The retinaldehyde reductase activity of RDH12 protects the cells from retinaldehyde-induced cell death, especially at high retinaldehyde concentrations, and this protective effect correlates with the lower levels of retinoic acid in RDH12-expressing cells. Disease-associated mutants of RDH12, T49M and I51N, exhibit significant residual activity in vitro, but are unable to control retinoic acid levels in the cells because of their dramatically reduced affinity for NADPH and much lower protein expression levels. These results suggest that RDH12 acts as a regulator of retinoic acid biosynthesis and protects photoreceptors against overproduction of retinoic acid from all-trans-retinaldehyde, which diffuses into the inner segments of photoreceptors from illuminated rhodopsin. These results provide a novel insight into the mechanism of retinal degeneration associated with mutations in RDH12 and are consistent with the observation that RDH12-null mice are highly susceptible to light-induced retinal apoptosis in cone and rod photoreceptors.

    Topics: Alcohol Oxidoreductases; Amino Acid Substitution; Animals; Apoptosis; Gene Expression Regulation, Enzymologic; Genetic Diseases, Inborn; Homeostasis; Humans; Light; Macaca mulatta; Mice; Mice, Mutant Strains; Mutation, Missense; NADP; Oxidation-Reduction; Photoreceptor Cells; Retinal Diseases; Retinaldehyde; Rhodopsin; Tretinoin

2007